NAT10 and endothelial dysfunction: Moreover, OE-NAT10 increased the proliferation (Fig. 2C), migration (Fig. 2D), and angiogenesis abilities (Fig. 2E) of Ang II-treated HUVECs, indicating that NAT10 overexpression inhibits Ang II-induced endothelial dysfunction and EndMT in HUVECs.